The major finding is the CV benefit. Fibrates seem to be much more potent in people with kidney disease, and this is important. Thus, overall, the results suggest that fibrates could be used more ...

Fibrate use was associated with new onset CKD, but a lower risk for kidney failure. Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising ...

Fibrates help lower cholesterol by reducing a type of fat in the blood. Doctors use them in the management of conditions such as dyslipidemia, heart disease, and stroke. While statins can lower ...